Antiplatelet Therapy for Improving Post-PCI Outcomes: Interpreting Current Treatment Guidelines for Optimal Management of the Post-ACS PatientByJason Cross, PharmD, RPhApril 2nd 2009
Percutaneous Coronary Intervention: Assessing Coronary Vascular Risk Associated With Bare-Metal and Drug-Eluting StentsBySarah A. Spinler, PharmD, FCCP, BCPS (AQ Cardiology)March 23rd 2009
Acute Coronary Syndromes: Morbidity, Mortality, and Pharmacoeconomic BurdenByDaniel M. Kolansky, MDMarch 23rd 2009
